A detailed history of Neuberger Berman Group LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 14,312 shares of IONS stock, worth $542,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,312
Previous 14,234 0.55%
Holding current value
$542,567
Previous $617,000 10.53%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$36.45 - $47.7 $2,843 - $3,720
78 Added 0.55%
14,312 $682,000
Q1 2024

May 13, 2024

BUY
$42.03 - $53.55 $598,255 - $762,230
14,234 New
14,234 $617,000
Q4 2023

Feb 09, 2024

SELL
$43.39 - $51.63 $66,647 - $79,303
-1,536 Reduced 9.89%
13,998 $708,000
Q3 2023

Nov 14, 2023

BUY
$38.5 - $47.13 $12,628 - $15,458
328 Added 2.16%
15,534 $704,000
Q2 2023

Aug 11, 2023

BUY
$34.73 - $43.33 $2,570 - $3,206
74 Added 0.49%
15,206 $623,000
Q1 2023

May 12, 2023

BUY
$33.58 - $41.2 $139,256 - $170,856
4,147 Added 37.75%
15,132 $540,000
Q4 2022

Feb 13, 2023

SELL
$37.12 - $46.52 $7,943 - $9,955
-214 Reduced 1.91%
10,985 $414,000
Q3 2022

Nov 15, 2022

BUY
$36.54 - $48.66 $4,129 - $5,498
113 Added 1.02%
11,199 $495,000
Q2 2022

Aug 15, 2022

BUY
$31.71 - $43.0 $351,537 - $476,698
11,086 New
11,086 $410,000
Q1 2019

May 13, 2019

SELL
$52.92 - $81.17 $282,645 - $433,528
-5,341 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $669,399 - $838,310
-15,611 Reduced 74.51%
5,341 $275,000
Q2 2018

Aug 13, 2018

BUY
$40.53 - $50.7 $604,383 - $756,038
14,912 Added 246.89%
20,952 $873,000
Q1 2018

May 08, 2018

SELL
$44.08 - $55.05 $212,994 - $266,001
-4,832 Reduced 44.44%
6,040 $266,000
Q4 2017

Feb 14, 2018

SELL
$50.3 - $64.39 $648,870 - $830,631
-12,900 Reduced 54.27%
10,872 $547,000
Q3 2017

Nov 15, 2017

BUY
$45.56 - $59.57 $1.08 Million - $1.42 Million
23,772
23,772 $1.21 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.38B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.